Pharmac to fund medicines for blood cancers, inflammatory bowel disease, eczema and arthritis
Source: PHARMAC More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, following Pharmac’s decision to widen access to four medicines for six health conditions from 1 May 2025. The medicines and health conditions are: venetoclax (brand name Venclexta) in combination with azacitidine or cytarabine for a type of … Read more